• 011-26907444
  • raghava@iiitd.ac.in

Welcome to Peptide Card of AntiTbPdb

This page displays user query in tabular form.

FWGLKGLKKFSKKL details
Primary information
ID antitb_1191,
Name25019413
N-Terminal modificationPin2 [14]
C-Terminal ModificationFWGLKGLKKFSKKL
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature14
SourceL
OriginCationic
SpeciesSynthetic
StrainShort variant of Pin2
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis H37Rv
Cell LineMIC = 20 ± 6.92 μg/ml or 11.92 ± 3.7 μM
Inhibition ConcentrationIn vitro
Sequence2014
CytotoxicityRBC
In vivo ModelNA
Lethal DoseHemolysis ( IC-50 = 418.4 [291–602])
Immune ResponceNone
Mechanism of ActionNA
TargetNA
Combination TherapyCell wall disruption
Other activitiesCell wall
PMIDNone
Year of PublicationAnti-bacterial (E. coli, S. aureus)
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1192,
Name25019413
N-Terminal modificationPin2 [14]
C-Terminal ModificationFWGLKGLKKFSKKL
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature14
SourceL
OriginCationic
SpeciesSynthetic
StrainShort variant of Pin3
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis muti-drug resistant strain (MDR) clinical isolate
Cell LineMIC = 10 ± 3.1 μg/ml or 6 ± 1.8 μM
Inhibition ConcentrationIn vitro
Sequence2014
CytotoxicityRBC
In vivo ModelNA
Lethal DoseHemolysis ( IC-50 = 418.4 [291–602])
Immune ResponceNone
Mechanism of ActionNA
TargetNA
Combination TherapyCell wall disruption
Other activitiesCell wall
PMIDNone
Year of PublicationAnti-bacterial (E. coli, S. aureus)
Tertiary Structure
(Technique)
Not Predicted),